Drs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma.
Read the full article:
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00317-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv